Nancy Bailey

576 total citations
8 papers, 409 citations indexed

About

Nancy Bailey is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Nancy Bailey has authored 8 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Cancer Research. Recurrent topics in Nancy Bailey's work include Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Nancy Bailey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). Nancy Bailey collaborates with scholars based in United States. Nancy Bailey's co-authors include F. Stephen Hodi, Patrick A. Ott, Mizuki Nishino, Nikhil H. Ramaiya, Abhishek Keraliya, Sree Harsha Tirumani, Anita Giobbie‐Hurder, Michael P. Manos, Elizabeth I. Buchbinder and Jason J. Luke and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Cancer Immunology Research.

In The Last Decade

Nancy Bailey

8 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Bailey United States	6	335	112	90	69	59	8	409
Hideki Kuwano Japan	7	137 0.4×	113 1.0×	108 1.2×	57 0.8×	31 0.5×	23	297
Ikuo Kamiyama Japan	10	187 0.6×	193 1.7×	85 0.9×	81 1.2×	23 0.4×	29	413
Atsuro Saijo Japan	11	187 0.6×	141 1.3×	82 0.9×	120 1.7×	33 0.6×	28	374
Norimitsu Kasahara Japan	10	196 0.6×	163 1.5×	26 0.3×	40 0.6×	30 0.5×	29	301
Yael Steinberg‐Silman Israel	7	307 0.9×	56 0.5×	74 0.8×	70 1.0×	48 0.8×	8	373
Nicholas P. Schaub United States	8	222 0.7×	48 0.4×	142 1.6×	66 1.0×	32 0.5×	8	403
Yoshiro Nakahara Japan	12	282 0.8×	255 2.3×	44 0.5×	55 0.8×	26 0.4×	42	414
Mazhar Ajaz United Kingdom	9	297 0.9×	87 0.8×	96 1.1×	147 2.1×	19 0.3×	12	424
Xiangjuan Ma China	9	274 0.8×	153 1.4×	53 0.6×	62 0.9×	69 1.2×	34	335
Kageaki Watanabe Japan	10	288 0.9×	211 1.9×	65 0.7×	52 0.8×	37 0.6×	47	406

Countries citing papers authored by Nancy Bailey

Since Specialization

Citations

This map shows the geographic impact of Nancy Bailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Bailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Bailey more than expected).

Fields of papers citing papers by Nancy Bailey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Bailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Bailey. The network helps show where Nancy Bailey may publish in the future.

Co-authorship network of co-authors of Nancy Bailey

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Bailey. A scholar is included among the top collaborators of Nancy Bailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Bailey. Nancy Bailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Buchbinder, Elizabeth I., Jason L. Weirather, Michael P. Manos, et al.. (2021). Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade. Cancer Medicine. 10(8). 2627–2635. 12 indexed citations

Nishino, Mizuki, Anita Giobbie‐Hurder, Michael P. Manos, et al.. (2017). Immune-Related Tumor Response Dynamics in Melanoma Patients Treated with Pembrolizumab: Identifying Markers for Clinical Outcome and Treatment Decisions. Clinical Cancer Research. 23(16). 4671–4679. 95 indexed citations

Nishino, Mizuki, Anita Giobbie‐Hurder, Michael P. Manos, et al.. (2017). Immune-related tumor response dynamics in melanoma patients (pts) treated with pembrolizumab: Identifying markers for clinical outcome and treatment decisions.. Journal of Clinical Oncology. 35(15_suppl). 9521–9521. 1 indexed citations

Garcia-Neuer, Marlene, Melina E. Marmarelis, Sushrut Jangi, et al.. (2017). Diagnostic Comparison of CT Scans and Colonoscopy for Immune-Related Colitis in Ipilimumab-Treated Advanced Melanoma Patients. Cancer Immunology Research. 5(4). 286–291. 44 indexed citations

Luke, Jason J., Mizuki Nishino, Anita Giobbie‐Hurder, et al.. (2015). Clinical experience and correlates of ipilimumab 3 mg/kg with GM-CSF in advanced melanoma.. Journal of Clinical Oncology. 33(15_suppl). e20025–e20025. 1 indexed citations

Tirumani, Sree Harsha, Nikhil H. Ramaiya, Abhishek Keraliya, et al.. (2015). Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab. Cancer Immunology Research. 3(10). 1185–1192. 191 indexed citations

Lee, Jonathan J., Lynette M. Sholl, Neal I. Lindeman, et al.. (2015). Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clinical Epigenetics. 7(1). 43 indexed citations

Luke, Jason J., Mizuki Nishino, Anita Giobbie‐Hurder, et al.. (2015). Single Institution Experience of Ipilimumab 3 mg/kg with Sargramostim (GM-CSF) in Metastatic Melanoma. Cancer Immunology Research. 3(9). 986–991. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact